PROFUSA, INC. Interest Income, Securities, Operating, Taxable
PROFUSA, INC. (PFSA) reported Interest Income, Securities, Operating, Taxable of $78.81 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeSecuritiesTaxable · last filed 2025-08-14
- PROFUSA, INC. interest income, securities, operating, taxable for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- PROFUSA, INC. interest income, securities, operating, taxable for the quarter ending 2025-03-31 was $78.81K, a 176.69% increase year-over-year.
- PROFUSA, INC. interest income, securities, operating, taxable for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- PROFUSA, INC. interest income, securities, operating, taxable for the quarter ending 2024-09-30 was -$1.00, a 100.00% decline year-over-year.
- PROFUSA, INC. interest income, securities, operating, taxable for fiscal 2024 was $204.46K, a 82.85% decline from fiscal 2023.
- PROFUSA, INC. interest income, securities, operating, taxable for fiscal 2023 was $1.19M.
| Period end | Interest Income, Securities, Operating, Taxable 3 month | Interest Income, Securities, Operating, Taxable 6 month | Interest Income, Securities, Operating, Taxable 9 month | Interest Income, Securities, Operating, Taxable 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $78.81K 10-Q · filed 2025-08-14 | $78.81K derived: sum of 3 quarters · filed 2025-08-14 | $78.81K derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | $78.81K 10-Q · filed 2025-06-13 | $78.81K derived: sum of 2 quarters · filed 2025-06-13 | $78.81K derived: sum of 3 quarters · filed 2025-06-13 | $254.79K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.00 derived: sum of 2 quarters · filed 2025-03-31 | $175.97K derived: sum of 3 quarters · filed 2025-08-14 | $204.46K 10-K · filed 2025-03-31 |
| 2024-09-30 | -$1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | $175.97K derived: sum of 2 quarters · filed 2025-08-14 | $204.46K 10-Q · filed 2024-12-17 | $225.46K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | $175.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $204.46K 10-Q · filed 2025-08-14 | $225.46K derived: sum of 3 quarters · filed 2025-08-14 | $519.46K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $28.48K 10-Q · filed 2025-06-13 | $49.48K derived: sum of 2 quarters · filed 2025-06-13 | $343.48K derived: sum of 3 quarters · filed 2025-06-13 | $343.48K derived: sum of 4 quarters · filed 2025-06-13 |
| 2023-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $315.00K derived: sum of 2 quarters · filed 2025-03-31 | $315.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.19M 10-K · filed 2025-03-31 |
| 2023-09-30 | $294.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | $294.00K derived: sum of 2 quarters · filed 2024-12-17 | $1.17M 10-Q · filed 2024-12-17 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-15 | $877.44K 10-Q · filed 2024-11-15 | ||
| 2023-03-31 | $877.44K 10-Q · filed 2024-10-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |